Home Tags HaystackHQ
A company pioneering a drug to delay cataracts from forming or slow their growth has won this year's $100,000 Enterprize competition. Adelaide-based Calpain Therapeutics' victory was announced earlier this month by University of Queensland Business School, which has run Australia's richest business-plan contest since 2000.
On World Sight Day, judges of the University of Queensland (UQ) Business School’s $100,000 Enterprize competition finals voted resoundingly for an innovation that could control the world’s single largest cause of blindness – cataract, a clouding of the eye’s lens among older populations. Calpain Therapeutics, an Adelaide startup that has developed a drug that can slow the onset of cataract, won the nation’s richest business plan competition, ahead of four others shortlisted.
The stealth startup, with the promise of making patent searches easier, better and more affordable, has been named among the five finalists of the University of Queensland Business School’s $100,000 Enterprize competition. “We're at an early stage of development. We have working prototypes, but do not yet have a publicly available working solution – although we hope to change that in the near future,” HaystackHQ told Anthill.
The University of Queensland Business School has announced the five finalists of its 2011 Enterprize competition. A drug to the delay the progression of cataracts, a stopping corrosion low-cost chemical mix, an environment friendly fabrication technology, an online international patent search tool and an internet hub that hosts competitions to build predictive models are the five ideas behind the finalists of the business competition.